A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer

NCT00649090 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
1549
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer